Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin.
Allan Roeske-NielsenJan-Eric MånssonHasim TekinKlaus RieneckKlaus BendtzenKarsten BuschardPublished in: Diabetes, obesity & metabolism (2023)
Sulfatide strongly inhibits fibroblast growth. We therefore suggest the addition of sulfatide to injectable commercial insulin formulations, which would reduce adverse fibroblast growth and improve well-being in patients with diabetes.